A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: A randomized, placebo-controlled, double-blind clinical trial

By Brinkhaus Benno   Hentschel Christian   Keudell Christoph Von   Schindler Gernot   Lindner Martin   Stützer Hartmut   Kohnen Ralf   Willich Stefan   Lehmacher Walter   Hahn Eckhart G.  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 8, 2005-08 ,pp. : 936-943

Informa Healthcare

Access to resources Recommend Favorite

Double-Blind Pilot Study of Mesalamine vs. Placebo for Treatment of Chronic Diarrhea and Nonspecific Colitis in Immunocompetent HIV Patients

By Rodríguez-Torres Maribel   Rodríguez-Orengo Jose   Ríos-Bedoya Carlos   Fernández-Carbia Alberto   Salgado-Mercado Rosa   Marxuach-Cuétara Acisclo  

Digestive Diseases and Sciences, Vol. 51, Iss. 1, 2006-01 ,pp. : 161-167

Springer Publishing Company

Access to resources Recommend Favorite

Citicoline in Intracerebral Haemorrhage: A Double-Blind, Randomized, Placebo-Controlled, Multi-Centre Pilot Study

By  

Cerebrovascular Diseases, Vol. 21, Iss. 5-6, 2006-05 ,pp. : 380-385

Karger

Access to resources Recommend Favorite

Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study


By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 7, Iss. 1, 2017-05 ,pp. : 136-142

Karger

Access to resources Recommend Favorite